There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 430-99-9 | MDL No. : | MFCD03424474 |
Formula : | C3H3FO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | TYCFGHUTYSLISP-UHFFFAOYSA-N |
M.W : | 90.05 | Pubchem ID : | 2782523 |
Synonyms : |
|
Num. heavy atoms : | 6 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 17.88 |
TPSA : | 37.3 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.36 cm/s |
Log Po/w (iLOGP) : | 0.85 |
Log Po/w (XLOGP3) : | 0.69 |
Log Po/w (WLOGP) : | 0.97 |
Log Po/w (MLOGP) : | 0.16 |
Log Po/w (SILICOS-IT) : | 0.1 |
Consensus Log Po/w : | 0.55 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -0.77 |
Solubility : | 15.4 mg/ml ; 0.171 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.05 |
Solubility : | 8.02 mg/ml ; 0.089 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | 0.12 |
Solubility : | 118.0 mg/ml ; 1.31 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.12 |
Signal Word: | Danger | Class: | 8 |
Precautionary Statements: | P260-P264-P270-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P405-P501 | UN#: | 3261 |
Hazard Statements: | H302-H314 | Packing Group: | Ⅱ |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 20℃; for 2 h; | In a 250 ml four-necked flask, 2-fluoropropenal (8.89 g, 0.12 mol)m-cpba 26 g (0.15 mol),Dichloromethane 30g, incubated at 20 stirring 2h, cooled to about 0 ,Filtration, the filtrate was concentrated to dryness to give crude 2-fluoroacrylic acid,Crystallization with 10g n-heptane to obtain 2-fluoro acrylic acid products.Yield 92percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70.9% | at 100℃; for 13 h; Autoclave | 8.98 g (71.87 mmol) of 1-bromo-1-fluoroethene, 8.01 g (79.2 mmol) of triethylamine, 51.5 mg (0.072 mmol) of dichloro[bis(diphenylphosphinophenyl)ether]palladium (II), and 36 mE of non-dried methanol were placed in a 1 50-mE stainless autoclave, and 1.0 MPaG carbon monoxide was introduced thereto, followed by stirring at 100° C. for 13 hours. After completion of the reaction, the autoclave was cooled, and the unreacted gas was purged. The autoclave was opened, and 186 mg (1.0 mmol) of hexafluorobenzenewas added as an internal standard substance, followed by stirring. The mixture was then allowed to stand for a short period of time to precipitate the salt. The supernatant was diluted with deuterated chloroform, and subjected to quantification based on 19F-NMR integral values. The diluted supernatant was found to contain 50.93 mmol (yield: 70.9percent) of 2-fluoroacrylic acid methyl ester, 10.13 mmol (yield:14.1percent) of 2-fluoroacrylic acid, and 8.12 mmol (recovery:11.3percent) of unreacted 1 -bromo-1 -fluoroethene. The conversion was 87.5percent, and the selectivity was 81.0percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With oxalyl dichloride; N,N-dimethyl-formamide; In dichloromethane; at 0 - 20℃; for 3h;Inert atmosphere; | General procedure: Oxalyl dichloride (1.56 mmol, 0.14 mL) was added to the solution of the tested acid (1.72 mmol) in CH2Cl2 (5 mL) and DMF (a drop, about 0.05 mL) at 0 C under Ar atmosphere within 10 min. After the solution was stirred for 3 h at the room temperature, a solution of 3a-i (1.32 mmol) in dichloromethane (8.0 mL) was added at 0 C. The reaction solution was then warmed to room temperature and stirred for overnight. After quenched with saturated NaHCO3 aqueous solution, the mixture was extracted with EtOAc (2×15 mL), and the combined organic layers were washed with brine (20 mL) and dried over NaSO4. After filtration and concentration, the residue was purified by column chromatography to give the acylated product with two rotamers, and the isolated yields were shown in Table 2. | |
With oxalyl dichloride; N,N-dimethyl-formamide; In dichloromethane; at 20℃; for 2.5h;Cooling with ice; | <strong>[430-99-9]2-fluoroacrylic acid</strong> (2.Oeq.) (54 mg) was dissolved in DCM (10 ml)3 drops of DMF were added,Under ice-cooling conditions,Oxalyl chloride (1.7 eq.) (44 [mu] v)In the ice bath conditions for 30min,Remove the ice bath,Natural recovery to room temperature,The reaction was carried out for 2 hours,(4-fluorophenylamino) -6-amino-7- (tetrahydrofuran-3-oxy) quinazoline(1 eq.) (112 mg) was dissolved in DCM (20 ml)Stir at 0 C for 5 min,Was added to the above acid chloride solution,Et3N (4 Oeq.) (169yL) was added,In the ice bath conditions for 30min,Remove the ice bath,After natural recovery to room temperature,The reaction was stirred overnight.After completion of the reaction,Concentrated to dry under reduced pressure crude,Purification by column chromatography (mobile phase 10: lDCM / MeOH) afforded N- (4- (3-chloro-4-fluorophenylamino) -7- (tetrahydrofuran-3-oxy) quinazoline- Yl) -2-fluorobut-2-enamide 80mg | |
With trichlorophosphate; at 80℃; | General procedure: We used indole 7 as starting material to synthesize interediates15a-c by the method reported in the literature [32]. Different substituted acrylic acids were chlorinated by POCl3 to obtain the corresponding acyl chloride at 80 C. Under an ice bath, differently substituted acryl chloride was dissolved in dichloromethane and stirred at 0 C for 10-30 min. Another intermediates 15a-c were added to the above acryl chloride solution, and then added NaHCO3 solid powder, stirred at 0 C for 0.5-3 h. After the reaction was completed, the reaction mixture was filtered and solvent was distilled off under reduced pressure. The crude product was purified using flash chromatography with dichloromethane/methanol(v/v, from 50:1 to 20:1) as eluents |
With oxalyl dichloride; N,N-dimethyl-formamide; In dichloromethane; at 20℃; for 2h;Inert atmosphere; | Add in a 50mL eggplant bottle<strong>[430-99-9]2-fluoroacrylic acid</strong> 113.07 mg (1.26 mmol).10 mL of dry dichloromethane was added to suspend it.Add oxalyl chloride 115 muL (1.36 mmol) and a drop of DMF,After argon gas was fully replaced, it was allowed to react at room temperature for 2 h.2-Fluoroacryloyl chloride was prepared, and after completion of the reaction, it was charged into a constant pressure dropping funnel.In another 50 mL eggplant bottle, compound 41 300 mg (1.05 mmol) was added.Dissolved in 10 mL of dry dichloromethane,Add 913 muL (5.23 mmol) of DIPEA,After the replacement with argon gas, the acid chloride solution was slowly added dropwise under ice bath.After the completion of the dropwise addition, the reaction was carried out for 1 h. After the reaction was completed by TLC, the reaction mixture was washed with water and brine, dried over anhydrous sodium sulfate andDichloromethane: methanol = 100:1).The product (42) was obtained in 247.00 mg.It was a white solid, yield: 65.80%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; In sodium hydroxide; | EXAMPLE 4 Synthesis of 2-fluoroacrylic Acid 31 g of 2-chloro-2-fluoropropionic acid were dissolved in 320 ml of a 2N NaOH solution and heated at 100° C. for 24 h. The medium was subsequently acidified with 140 ml of 2N HCl. The 2-fluoroacrylic acid was extracted with two times 200 ml of diethyl ether. 20 g of 2-fluoroacrylic acid were recovered after evaporation of the ether. The yield of 2-fluoroacrylic acid, based on the amount of 2-chloro-2-fluoropropionic acid employed, was 90percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | Example 149; Compound of Formula (Iaa) wherein M=tert-butoxy, Q=4-tert-butyl-3-methoxybenzoyl, Z=1,3-thiazol-2-yl, X=fluoro, Y=hydroxymethyl, J=1H-pyrazol-1-ylmethylStep 149a. A solution of <strong>[430-99-9]2-fluoroacrylic acid</strong> (2 g, 22 mmol) in dichloromethane (80 mL) was added DCC (4.58 g, 22 mmol). at 0° C. The resulting mixture was stirred at 0° C. for 15 min before addition of a solution of methyl (R)-(-)-mandelate (4.06 g, 24 mmol) and DMAP (136 mg, 0.11 mmol) in 20 mL of dichloromethane. The mixture was stirred at rt for 16 h before being filtered and the organic solution was washed with brine, dried (Na2SO4) and evaporated. The residue was chromatographed (silica, hexane-EtOAc) to give the desired compound (2.9 g, 55percent) as white crystals.1H NMR (CDCl3) 7.50 (m, 2H), 7.43 (m, 3H), 6.09 (s, 1H), 5.83 (dd, 1H), 5.45 (dd, 1H), 3.77 (s, 3H).13C NMR (CDCl3): 168.7, 159.7 (d), 152.9 (d), 133.3, 129.8, 129.2, 127.9, 104.3, 75.6, 53.0. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With fluorine; sodium fluoride; at -78℃;Inert atmosphere; | Example 2: Synthesis of 2,3-difluoropropionic acid (G) [0041] To a solution of acrylic acid in 2H,3H-decafluoropentane was added sodium fluoride as scavenger for HF. The suspension was cooled to -78C under vigorous stirring. Fluorine was introduced to the mixture under the same conditions as example 1. After the reaction, the mixture was filtered and analyzed by GC/MS. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77% | With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide; triethylamine; In ethyl acetate; for 60h;Inert atmosphere; | To a suspension of 6-bromo-2,2-dimethyl-1-vinyl-2,3-dihydro-1H-inden-1-amine (1.12 g, 4.21 mmol) and 2-fluoropropenoic acid (0.568 g, 6.31 mmol) in dry EtOAc (20 mL)were added 1-propanephosphonic acid cyclic anhydride (T3P) (3.76 mL, 6.31 mmol) and triethylamine (1.47 mL, 10.52 mmol) under nitrogen. After 1.5 h, more 2-fluoropropenoic acid (0.189 g, 2.10 mmol) and 1-propanephosphonic acid cyclic anhydride (T3P) (1.25 mL, 2.10 mmol) was added and stirring continued. After a total of 2.5 days, water was added and the phases were separated. The aq layer was extracted twice with EtOAc and the combined organics were dried over MgSO4, filtered and concentrated. Purification by column chromatography using a gradient of 0-10percent EtOAc in heptane as eluent afforded 1.097 g(77percent) of the title compound. 1H NMR (500 MHz, CHLOROFORM-d) delta 1.10 (s, 3 H), 1.22 (s,3 H), 2.67 -2.77 (m, 2 H), 4.71 (d, 1 H), 5.13 (dd, 1 H), 5.23 (d, 1 H), 5.62-5.75 (m, 1 H), 6.36 (dd, 1 H), 6.62 (br. s., 1 H), 7.08 (d, 1 H), 7.38 (dd, 1 H), 7.53 (d, 1 H). MS (ES-) m/z336,338 [M-H]- |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
27% | With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide; triethylamine; In ethyl acetate; at 0 - 20℃; for 75h;Inert atmosphere; | To a suspension of 1?-ethenyl-6?-(3 -fluoropropoxy)-4-[(2H3)methyloxy]-1?,3dihydrospiro[cyclohexane-1,2?-inden]-1?-amine (1.376 g, 4.09 mmol) and in dry ethyl acetate (30 mL) were 1-propanephosphonic acid cyclic anhydride (3.67 mL, 6.14 mmol) and triethylamine (0.570 ml, 4.09 mmol) added at 0 °C under an nitrogen atmosphere. The reaction mixture was then allowed to reach r.t. The mixture was stirred 3 days, then more 1-propanephosphonic acid cyclic anhydride (1.223 mL, 2.05 mmol) and triethylamine (0.285 mL, 2.05 mmol) was added, stirred for another 3h. Water was then added and the phases were separated. The aqueous phase was extracted with EtOAc and the combined organics were dried over Na2SO4 and evaporated. Purification of the residue by silica gel chromatographyusing heptane/ethylacetate 5:1-4:1-3:1 as eluant gave the title compound (0.45 g, 27 percent yield).The product was used as such in the next step. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
43% | 2-Fluoroacrylic acid (1.45 g, 16.06 mmol) and HBTU (7.31 g, 19.27 mmol) were dissolved in dichloromethane (30 mL). Triethylamine (3.36 mL, 24.09 mmol) was added and the reaction was stuffed for 6 min. 6?-Bromo-1?-ethenyl-4-methoxy-1?,3?-dihydrospiro[cyclohexane-1,2?-inden]-1?-amine (mixture of isomers) (2.7 g, 8.03 mmol) was added as a solution in dichloromethane (20 mL). The reaction was stuffed for 16 h. The reaction mixture was poured in water. The phases were separated and the aqueous phase extracted with dichloromethane. The combined organic phases were dried over MgSO4, filtered and the solvent evaporated. Column chromatography (silica gel) usingdichloromethane yielded 1.4 g (43 percent) of the title compound. MS (ES-) mlz 406, 408 [M-H]-. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
14.46% | 2-Fluoroacrylic acid (3.04 g, 33.70 mmol) and 0-(lH-Benzotriazol-l-yl)-N,N,N',N'- tetramethyluronium hexafluorophosphate (25.6 g, 67.41 mmol) were dissolved in DCM (60 mL). Triethylamine (11.74 mL, 84.26 mmol) was added and the reaction was stirred for 6 min. ( s,4's)-5-Bromo-4'-methoxy-3-vinyl-3H-spiro[benzofuran-2,r-cyclohexan]-3-amine (5.7 g, 16.85 mmol) was added as a solution in DCM (40 mL). The reaction was stirred for 16 h. The reaction mixture was poured in water. The phases were separated and the aqueous phase extracted with DCM. The combined organic phases were dried over MgSO4., filtered and the solvent evaporated. The product was purified by column chromatography using MeOH 0percent to 10percent in DCM to yield 1 g (14.46 percent). 1H NMR (500 MHz, CDC13) delta ppm 1.53 - 1.60 (m, 1 H) 1.60 - 1.72 (m, 2 H) 1.89 - 2.10 (m, 5 H) 3.23 (tt, 3.98 Hz, 1 H) 3.37 (s, 3 H) 4.81 (d, 1 H) 5.18 (dd, 1 H) 5.29 (d, 1 H) 5.64 - 5.77 (m, 1 H) 6.49 - 6.59 (m, 2 H) 6.74 (d, 1 H) 7.32 (d, 1 H) 7.37 (dd, 1 H). MS (ES-) m/z 408, 410 [M-H]~ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
37% | 2-Fluoroacrylic acid (2.042 g, 22.68 mmol) and O-( 1 H-benzotriazol- 1 -yl)-N,N,N?,N?15 tetramethyluronium hexafluorophosphate (10.32 g, 27.22 mmol) were taken up in DCM (30mL) and TEA (4.74 mL, 34.02 mmol) was added. The reaction was stirred for 6 min 6-bromo-3,3-dimethyl-4-vinylchroman-4-amine (3.2 g, 11.34 mmol) was added as a solution in DCM (20 mL) and the reaction was stirred for 16 h. The reaction mixture was poured into brine and the phases were separated. The aqueous phase was extracted with DCM. The combined organic phases were dried over MgSO4, filtered and the solvent evaporated. Theproduct was purified by column chromatography using EtOAc 0percent to 100percent in heptane to yield1.5 g (37 percent) of the title compound. 1H NMR (500 MHz, DMSO-d6) delta ppm 0.92 (s, 3 H) 0.99(s, 3 H) 3.80 - 3.99 (m, 2 H) 4.72 (d, 1 H) 5.28 (dd, 1 H) 5.36 (d, 1 H) 5.43 - 5.59 (m, 1 H)6.45 (dd, 1 H) 6.77 (d, 1 H) 7.27 (s, 1 H) 7.31 (d, 1 H) 7.55 (br. s., 1 H). MS (ES+) m/z 354,356 [M+H]+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; 3-[(diethoxyphosphinyl)oxy]-1,2,3-benzotriazin-4(3H)-one; In N,N-dimethyl acetamide; at 50℃; for 12h;Inert atmosphere; Sealed tube; | Ethyl 4-(3-aminophenyl)-7H-pyrrolo[2,3- 0.10 mmol), <strong>[430-99-9]2-fluoroacrylic acid</strong> (0.013 g, 0.15 mmol), 3-[(diethoxyphosphoryl)oxy]- l,2,3-benzotriazin-4(3H)-one (0.060 g, 0.20 mmol), and DIPEA (0.070 mL, 0.40 mmol) were suspended in DMA (1.0 mL) in a sealed tube. The reaction mixture was purged with argon and the reaction flask was capped and heated to 50 °C for 12 hours. The completed reaction was passed through a syringe filter, and was directly purified by reverse phase HPLC using an acetonitrile gradient in water with 0.1percent NH4OH modifier to afford ethyl 4-{3-[(2-fluoroacryloyl)amino]phenyl}-7H-pyrrolo[2,3-<i]pyrimidine-5- carboxylate. LRMS (ESI) calc'd for C18H] 6FN403 [M+H]+: 355, found 355. 1H NMR (600 MHz, DMSO-D6) delta 12.99 (s, 1H), 10.44 (s, 1H), 8.91 (s, 1H), 8.32 (s, 1H), 8.09 (t, J= 1.8 Hz, 1H), 7.87 (ddd, J= 1.1, 2.1, 8.0 Hz, 1H), 7.45 (t, J= 7.8 Hz, 1H), 7.40 (dt, J = 1.3, 7.7 Hz, 1H), 5.72 (dd, J = 3.6, 47.6 Hz, 1H), 5.44 (dd, J = 3.7, 15.6 Hz, 1H), 3.85 (q, J = 7.1 Hz, 2H), 0.84 (t, J = 7.1 Hz, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; | The crude product (5.6 mg) of (S)-3-((3,5-dimethoxyphenyl)ethynyl)-1-(pyrrolidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine obtained in Example 2 as an intermediate, 4-(dimethylamino)but-2-enoic acid hydrochloride (6.3 mg), and HATU (15 mg) were dissolved in DMF (1.0 ml). DIPEA (50 mul) was added thereto, followed by stirring overnight. Chloroform and water were added to the reaction mixture to separate the organic layer. After being washed with a saturated sodium chloride solution, the organic layer was dried over anhydrous sodium sulfate, and the solvent was then distilled off under reduced pressure. The resulting residue was purified by preparative reversed-phase HPLC purification (water/acetonitrile (0.1percent formic acid)) to obtain the title compound as a colorless, amorphous substance (2.3 mg) | |
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; | [0293]The crude product (5.6 mg) of (S)-3-((3,5-dimethoxyphenyl)ethynyl)-1-(pyrrolidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine obtained in Example 2 as an intermediate, 4-(dimethylamino)but-2-enoic acid hydrochloride (6.3 mg), and HATU (15 mg) were dissolved in DMF (1.0 ml). DIPEA (50 mul) was added thereto, followed by stirring overnight. Chloroform and water were added to the reaction mixture to separate the organic layer. After being washed with a saturated sodium chloride solution, the organic layer was dried over anhydrous sodium sulfate, and the solvent was then distilled off under reduced pressure. The resulting residue was purified by preparative reversed-phase HPLC purification (water/acetonitrile (0.1percent formic acid)) to obtain the title compound as a colorless, amorphous substance (2.3 mg). Table 1 shows the physical properties thereof. [0295] In accordance with Example 4, except that <strong>[430-99-9]2-fluoro-acrylic acid</strong> was used in place of 4-(dimethylamino)but-2-enoic acid hydrochloride, the title compound was obtained as a colorless, amorphous substance. Table 2 shows the physical properties thereof. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 0℃; for 0.25h; | Example 1345-amino-3-[4-(4-chlorophenoxy)phenyl]-1 -[(3R)-1 -(2-fluoroacryloyl)piperidin-3-yl]-I H-pyrazole-4-carboxamide To a solution of (R)-5-amino-3-(4-(4-chlorophenoxy)phenyl)-1 -(piperidin-3-yl)-1 Hpyrazole-4-carboxamide (prepared as described in Example 13, step 7) (79.1 mg, 0.192 mmol) in N,N-dimethylformamide (2.00 mL)was cooled to 0°C. 2-(1H- Benzotriazol-1-yl)tris(dimethylamino)phosphonium hexafluorophosphate (106 mg, 0.24 mmol), N,N-diisopropylethylamine (65.3 mg, 0.48 mmol) and <strong>[430-99-9]2-fluoroacrylic acid</strong> (21.69mg, 0.24 mmol) were added at 0°C. The reaction mixture was stirred for 15 mm at 0°C and then quenched by pouring over ice water. The solid was filtered and purified by reverse phase HPLC to afford the title compound. MS (M+H) m/z 484.1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 0℃; for 0.5h; | Example 1505-amino-3-[4-(2,4-difluorophenoxy)phenyl]-1 -[(3R)-1 -(2-fluoroacryloyl)piperidin-3- yl]-l H-pyrazole-4-carboxamide To a solution of (R)-5-amino-3-(4-(2,4-difluorophenoxy)phenyl)-1 -(piperidin-3-yl)-H-pyrazole-4-carboxamide (prepared as described in Example 26, step 1) (200 mg,0.48 mmol) in N,N-dimethylformanide (3 mL) at 0 °C was added (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (235 mg, 0.53 mmol), N, N-diisopropylethylamine (0.22 mL, 1.21 mmol) and <strong>[430-99-9]2-fluoroacrylic acid</strong> (43.6 mg, 0.48 mmol). After 30 mm, the mixture was poured into water/ethyl acetate and the layers seperated. The organic layer was dried (Na2SO4) and concentrated. The crude product was purified by reverse-phase HPLC to afford the title compound. 1H NMR (600 MHz,DMSO-d6) 6 ppm 1.57 (m, 1 H), 1.89 - 2.09 (m, 3 H), 2.97 (m, 0.5 H), 3.22 (m, 1 H),3.61 (m, 0.5 H), 3.97 (m, 1 H), 4.13 - 4.42 (m, 2 H), 5.11 - 5.38 (m, 2 H), 6.45 (br. s., 2H), 7.00 - 7.09 (m, 2 H), 7.15 - 7.24 (m, 1 H), 7.42-7.38 (m, 1 H), 7.51 - 7.59 (m, 3 H).MS (M+H) m/z486.1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 0℃; for 0.5h; | Example 1655-amino-I -[(3R)-I -(2-fluoroacryloyl)piperidin-3-yl]-3-(4-[6-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)-I H-pyrazole-4-carboxamide (Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (218 mg, 0.49 mmol), diisopropylamine (0.2 mL, 1.12 mmol) and <strong>[430-99-9]2-fluoroacrylic acid</strong>(40.3 mg, 0.45 mmol) were added to a solution of (R)-5-amino-1-(piperidin-3-yl)-3-(4- ((6-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)- 1 H-pyrazole-4-carboxam ide (prepared as described in Example, step 2) (200 mg, 0.45 mmol) in N,N-dimethylformamide (3 mL) at 0 °C. After 30 mm, the mixture was poured into water/ethyl acetate and the layers separated. The organic layer was dried (Na2504) and concentrated. The crude productwas purified by reverse phase HPLC to afford the title compound. 1H NMR (600 MHz,DMSO-d6) 6 ppm 8.18 (t, J=7.69 Hz, 1 H), 7.70 (d, J=7.47 Hz, 1 H), 7.62 (d, J=8.35 Hz,2 H), 7.41 (d, J=8.35 Hz, 1 H), 7.27 - 7.34 (m, 2 H), 6.45 (s, 2 H), 5.31 (br. s., 1 H), 5.11-5.26 (m, 2 H), 4.10-4.44 (m, 3 H), 3.79-4.06 (m, 1 H), 3.66 (m, 1 H), 3.26 (m, 1 H),2.96 (m., 1 H), 2.07 (m, 1 H), 1.95 (d, J=12.30 Hz, 1 H), 1.58 (m, 1 H). MS (M+H) m/z519.1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | To a solution of <strong>[430-99-9]2-fluoro-acrylic acid</strong> (2.0 eq.) in DCM (10 ml) were added 3 drops of DMF, under an ice bath, oxalyl chloride (1.8 eq.) was added dropwise and the mixture reacted under the ice bath for 30 mins, then the ice bath was removed, after the mixture was recovered to room temperature, reacted for 2 hours. A solution of N-(3-chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)-quinazolin-4,6-diamine (1.0 eq.) that was obtained in previous step in DCM (20 ml) stirred at 0° C. for 5 mins, and was added into the acyl chloride solution, and then Et3N (4.0 eq.) was added, the mixture reacted for 30 mins under an ice bath, then the ice bath was removed, after the mixture was recovered to room temperature, stirred overnight. After the reaction finished, the mixture was concentrated to dryness under reduced pressure, and the crude product was purified by column chromatography (mobile phase 10:1 DCM/MeOH) to give a pale yellow solid of N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-morpholinopropoxy)quinazolin-6-yl)-2-fluoroacrylamide (50percent yield). [0326] 1H NMR (500 MHz, DMSO): delta 9.83 (s, 1H), 9.76 (d, J=1.5 Hz, 1H), 8.72 (s, 1H), 8.58 (s, 1H), 8.17 (dd, J=6.9, 2.6 Hz, 1H), 7.82 (m, 1H), 7.43 (t, J=9.1 Hz, 1H), 7.31 (s, 1H), 5.77 (dd, J=48.1, 3.7 Hz, 1H), 5.52 (dd, J=15.7, 3.7 Hz, 1H), 4.25 (t, J=6.0 Hz, 2H), 3.58 (t, J=4.4 Hz, 4H), 2.47 (t, J=7.1 Hz, 2H), 2.37 (s, 4H), 1.99-1.92 (m, 2H). HRMS (ESI): m/z calcd for (C24H24ClF2N5O3+H)+: 504.1614. found: 504.1625. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
10% | With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide; triethylamine; In ethyl acetate; 1,2-dichloro-ethane; at 100℃; for 3h;Microwave irradiation; | To a suspension of amine salt E1.1 (1 .00g, 3.90 mmol), <strong>[430-99-9]2-fluoroacrylic acid</strong> (0.530g, 5.86 mmol), and triethylamine (1 .19g, 1 1 .71 mmol) in dichloroethane (10 mL) at room temperature was added a solution of propyl phosphoric anhydride (50percent wt) (1.86g, 5.86 mmol, a 50percent wt solution in EtOAc was used). The reaction was then heated in the mircrowave at 100 C for 3 hrs. The reaction was then dilluted with ethyl acetate (100 mL), washed with saturated aqueous NaHCO3 (100 mL) and water (100mL), layers separated, and the organic layer dried over Na2S04 and concentrated in vacuo to afford a residue which was purified using column chromatography over silica gel (0->50percent MeOH/EtOAc) to afford the desired product as a beige solid (0.1 10g, 10percent yield). LC-MS: mass calculated for Ci4Hi2CIFN30 [M+H]+ 291 .7, found 292.2; tR= 0.678 min. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
4 mg | With dicyclohexyl-carbodiimide; In chloroform; at 0 - 20℃; | Example - 110 N-(2-(6-(3 -(296-dich lo ro-3,5-dimeth oxy pheny -methy lureido)py rimid in-4-y lamin o)- phenyI)-2-fluoroacrylamide The compound was synthesized following the approach outlined in Procedure 2 A (Example 100), modifying step (i) to the following procedure: To a solution of I-[6-(2-amino- phenylamino)-pyrimidin- 4-yl]-3-(2,6-dichloro-3,5-dimethoxy-phenyl)-l-methyl-urea (130 mg, mixed with tetrachloro aniline) and DCC (118 mg, 0.56 mmol) in chloroform (100 mL) was added a solution of <strong>[430-99-9]2-fluoroacrylic acid</strong> (50 mg, 0.56 mmol) in chloroform (50 mL) at 0 °C, and the resulting mixture was stirred at room temperature overnight. Water (1 mL) was added to quench the reaction. The mixture was concentrated and the residue was purified by reverse phase column and prep-TLC to obtain the title compound (4 mg, yield: 5percent). FontWeight="Bold" FontSize="10" H NMR (400 MHz, CDC13) delta 12.17 (s, 1H), 8.45 (s, 1H), 8.35 (s, 1H), 7.84 (d, 1H), 7.37 (d, 1H), 7.29 (t, 1H), 7.26 (t, 1H), 6.47 (s, 1H), 5.94 (s, 1H), 5.78 (dd, 1H), 5,21 (dd, 1H), 3.85 (s, 6H), 3.25 (s, 3H); MS (ESI): 535 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | Intermediate-173: (S)-1-(3-(6-(benzylamino)-2-((4-(2-methoxyethoxy)phenyl)amino)-9H- purin-9-yl)piperidin-1-yl)-2-fluoroprop-2-en-1-oneThe title compound was prepared by following a procedure similar to that described in Intermediate-160 using Intermediate 171 (300 mg, 0.633 mmol), <strong>[430-99-9]2-fluoroacrylic acid</strong> (57.0 mg, 0.633 mmol), HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5- b]pyridinium 3-oxid hexafluorophosphate) (289 mg, 0.760 mmol) and TEA (128 mg, 1.267 mmol) to afford title compound (300 mg, 87percent yield) as brown solid. 1H NMR (400 MHz, DMSO-d6) 8.77 (s, 1H), 8.15 (s, 1H), 7.95 (s, 1H), 7.74? 7.50 (m, 2H), 7.47? 7.15 (m, 6H), 6.78 (d, J = 8.7 Hz, 2H), 5.23 (d, J = 49.9 Hz, 1H), 4.69 (s, 2H), 4.51? 4.17 (m, 1H), 4.02 (t, J = 7.0 Hz, 4H), 3.68? 3.59 (m, 2H), 3.31 (d, J = 1.5 Hz, 3H), 3.06 (d, J = 9.2 Hz, 2H), 1.99 (s, 2H), 1.91 (s, 1H), 1.60 (s, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In tetrahydrofuran; at 20℃; for 3.16667h; | Intermediate-93: N-(3-(6-(Dibenzylamino)-2-((4-fluorophenyl) amino)-9H-purin-9- yl)phenyl)-2-fluoroacrylamideThe title compound was prepared by following a procedure similar to that described in Intermediate-7 using Intermediate-90 (500 mg, 0.970 mmol), <strong>[430-99-9]2-fluoroacrylic acid</strong> (105 mg, 1.164 mmol), HATU (442 mg, 1.164 mmol) and TEA (294 mg, 2.91 mmol) to afford title compound (510 mg, 0.868 mmol, 89 percent yield) as a off-white solid. MS (M+H+) m/z 588.20. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
18% | <strong>[430-99-9]2-fluoroacrylic acid</strong> (11 mg, 0.134 mmol, 1.2 eq.), HATU (53 mg, 0.140 mmol, 1.3 eq.) and N, N-diisopropylethylamine (42 mg, 0.324 mmol, 1.0 eq.) were subsequently added to a solution of 3-(2-fluoro-4-(2,3,5,6-tetrafluorophenoxy)phenyl)-1-((R)-pyrrolidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (50 mg, 0.108 mmol, 1.0 eq.) in dichloromethane (10 mL) at 0° C. The reaction was stirred at room temperature for 5 hours, diluted with water (10 mL), and then extracted with dichloromethane (10 mL*3). The combined organic phases were dried over anhydrous sodium sulfate, and concentrated to spin dry, the crude product was isolated by HPLC reverse phase column (mobile phase in C18: acetonitrile/water/0.5percent HCl, gradient: 10percent-100percent (volume ratio)) to give the title compound hydrochloride (10 mg, yield: 18percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1.74 g | With dmap; diisopropyl-carbodiimide; In dichloromethane; at 20℃; for 5h; | Compounds represented in a reaction vessel equipped with a dropping funnel by the formula (I-8-9) 2.14g (4.87 mmol), <strong>[430-99-9]2-fluoro-acrylic acid</strong> 0.48 g (5.36 mmol), N, N- dimethylaminopyridine0.0595g (0.487 mmol), dichloromethane was added 10mL. With ice-cooling was added dropwiseN, N- diisopropylcarbodiimide 0.74g a (5.85 mmol). After stirring at room temperature for 5 hours, filtered, and purified by column chromatography (silica gel) and recrystallization to givethe compound 1.74g of formula (I-8). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60 mg | <strong>[430-99-9]2-fluoroacrylic acid</strong> (2.Oeq.) (40 mg) was dissolved in DCM (10 ml)3 drops of DMF were added,Under ice-cooling conditions,Oxalyl chloride (1.8 eq.) (33 [mu]In the ice bath conditions for 30min,Remove the ice bath,Natural recovery to room temperature,The reaction was carried out for 2 hours,A solution of the above-mentioned product 4- (3-chloro-4-fluorophenylamino) -3-cyano-6-amino-7-ethoxyquinazoline(Leq.) (107 mg) was dissolved in DCM (20 ml)Stir at 0 ° C for 5 min,Was added to the above acid chloride solution,Et3N (4 · Oeq ?) (169yL) was added,In the ice bath conditions for 30min,Remove the ice bath,After natural recovery to room temperature,The reaction was stirred overnight.After completion of the reaction,Concentrated to dry under reduced pressure crude,Purification by column chromatography (mobile phase 10: lDCM / MeOH) gave pale yellow N- (4- (3 -methoxy-4-benzoyl) -3-ethoxy-7-ethoxy- _ Base _2 _ gas acrylamide ugly amine,60 mg. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
35% | With dicyclohexyl-carbodiimide; In dichloromethane; at 20℃; for 4h;Reflux; | 4a (548mg, 1.3mmol), 2fluoroacrylicacid (117mg, 1.3mmol) was dissolved in 5ml of methylene chloride at roomtemperature was added dropwise DCC (267mg, 1.3mmol) in dichloromethane (5ml) was refluxed for 4 hours. Aftercompletion of the reaction, after cooling to room temperature, suction filtered, the filtrate was concentrated and separated bycolumn chromatography (petroleum ether: ethyl acetate: triethylamine = 2:1:0.1) to give a white solid 207mg, yield 35percent, |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65 mg | With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; for 1h; | To a solution of (R)-4-amino-3-(4-phenoxyphenyl)- I -(piperidin-3-yl)- 1H-imidazo{4,5-c]pyridin-2(3H)-one (154 mg, 0.38 mmol, 1.0 equiv) in 2 mL of DMF wasadded diisopropylethylamine (0.2 mL, 1.1 mmol). <strong>[430-99-9]2-fluoroprop-2-enoic acid</strong> (51.8 mg, 0.580 mmol) was added followed by HATU (97 mg, 1.1 mmol). After stirring lh, the material was purified directly by Prep HPLC (Shimadzu, C18 column; mobile phase water with 0.05percent TFA and ACN (10percent to 90percent over 20 mm). The purified fractions were dilutedwith saturated sodium bicarbonate and DCM and the layers separated. The organic layer was dried with MgSO4, filtered and concentrated. It was dissolved in a minimum of wateracetonitrile and lyophilized to obtain 65 mg of(R)-4-amino-1-(1-(2- fluoroacryloyl)piperidin-3-yl)-3 -(4-phenoxyphenyl)- I H-imidazo[4,5-cjpyridin-2(3H)-onea white solid. LC-MS mlz: 474.1 (M÷1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; | To a solution of intermediate 10-b (100 mg, 0.19 mmol) in DMF (2 ml) were sequentially added DIPEA (165 muIota, 0.95 mmol), EDC (55 mg, 0.28 mmol), HOBt (44 mg, 0.28 mmol) and <strong>[430-99-9]2-fluoroacrylic acid</strong> (21 mg, 0.23 mmol) and the reaction was stirred overnight at room temperature. A saturated aqueous solution of ammonium chloride and ethyl acetate were added, the organic layer was separated, washed with brine, dried over MgS04, filtered and concentrated under reduced pressure. Purification by silica gel chromatography provided Compound 20 as a white solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
14.1%; 70.9% | With dichloro[bis(2-(diphenylphosphino)phenyl)ether]palladium(ll); triethylamine; at 100℃; under 7500.75 Torr; for 13h;Autoclave; | 8.98 g (71.87 mmol) of 1-bromo-1-fluoroethene, 8.01 g (79.2 mmol) of triethylamine, 51.5 mg (0.072 mmol) of dichloro[bis(diphenylphosphinophenyl)ether]palladium (II), and 36 mE of non-dried methanol were placed in a 1 50-mE stainless autoclave, and 1.0 MPaG carbon monoxide was introduced thereto, followed by stirring at 100° C. for 13 hours. After completion of the reaction, the autoclave was cooled, and the unreacted gas was purged. The autoclave was opened, and 186 mg (1.0 mmol) of hexafluorobenzenewas added as an internal standard substance, followed by stirring. The mixture was then allowed to stand for a short period of time to precipitate the salt. The supernatant was diluted with deuterated chloroform, and subjected to quantification based on 19F-NMR integral values. The diluted supernatant was found to contain 50.93 mmol (yield: 70.9percent) of 2-fluoroacrylic acid methyl ester, 10.13 mmol (yield:14.1percent) of 2-fluoroacrylic acid, and 8.12 mmol (recovery:11.3percent) of unreacted 1 -bromo-1 -fluoroethene. The conversion was 87.5percent, and the selectivity was 81.0percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; diisopropyl-carbodiimide; In dichloromethane; | A compound represented by Formula (1-12-11), <strong>[430-99-9]2-fluoroacrylic acid</strong>, N,N-dimethylaminopyridine, and dichloromethane were put into a reaction container. Diisopropylcarbodiimide was dropped, followedby stirring. After ordinary post-treatment was performed, purification was performed by column chromatography (silica gel) to obtain a compound represented by Formula (1-12-12). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; diisopropyl-carbodiimide; In dichloromethane;Inert atmosphere; Cooling; | 2?fluoroacrylic acid, a compound represent;ed by Formula (1-13-i) , N, N-dimethylaminopyridine, and dichloromethane were put into a reaction container under a nitrogen atmosphere. With ice cooling, diisopropylcarbodiimide was added, followed by stirring. After ordinary post-treatment was performed, purification was performeciby column chromatocjraphy (silica gel) toohtainaccmpound represented by Formula (1-13?2) | |
18.9 g | With toluene-4-sulfonic acid; In toluene; for 8h;Dean-Stark; Reflux; | In a reaction vessel equipped with a Dean-Stark apparatus, 15.0 g of the compound represented by the formula (1-6-8), 11.9 g of <strong>[430-99-9]2-fluoroacrylic acid</strong>, 0.8 g of p-toluenesulfonic acid monohydrate, 150 mL of toluene And the mixture was heated under reflux for 8 hours while removing water. After washing with a saturated aqueous solution of sodium bicarbonate and brine, the solvent was distilled off to obtain 18.9 g of a compound represented by the formula (I-6-9). |
5.2 g | With dmap; diisopropyl-carbodiimide; In dichloromethane;Cooling with ice; Inert atmosphere; | In a nitrogen atmosphere, 3.0 g of <strong>[430-99-9]2-fluoroacrylic acid</strong>, 4.2 g of a compound represented by the formula (I-8-1), 0.2 g of N,N-dimethylaminopyridine, and 40 mL o dichloromethane were put in a reactor. With cooling with ice, 5.0 g of diisopropylcarbodiimide was added thereto and stirred. After ordinary post-treatment, this was purified through column chromatography to give 5.2 g of a compound represented by the formula (I-8-2). |
15.2 g | With toluene-4-sulfonic acid; In toluene; for 8h;Dean-Stark; Reflux; | In a reaction vessel equipped with a Dean-Stark apparatus and a condenser, 10.0 g of the compound represented by the formula (D-5-1)7.9 g of <strong>[430-99-9]2-fluoroacrylic acid</strong>,0.8 g of p-toluenesulfonic acid monohydrate,150 mL of toluene was added and heated under reflux for 8 hours while removing water.After washing with a saturated aqueous solution of sodium hydrogen carbonate and brine, the solvent was distilled off to obtain 15.2 g of a compound represented by the formula (D-5-2). |
10.1 g | With toluene-4-sulfonic acid; In di-isopropyl ether; cyclohexane; for 12h;Dean-Stark; Reflux; | 8.0 g of the compound represented by the formula (I-69-1), 8.7 g of <strong>[430-99-9]2-fluoroacrylic acid</strong>, 0.6 g of p-toluenesulfonic acid monohydrate, 100 mL of cyclohexane and 50 mL of diisopropyl ether were put into a reactor equipped with a Dean-Stark apparatus. While removing water, this was heated under reflux for 12 hours. This was diluted with dichloromethane, and washed sequentially with an aqueous solution of 5percent sodium hydrogencarbonate and salt water. Purification through column chromatography (silica gel, dichloromethane) gave 10.1 g of the compound represented by the formula (I-69-2). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine; In dichloromethane; at 20℃; for 8h; | (R) -3- (4-phenoxyphenyl) -1- (tetrahydropyrrole-2-methyl) -1H-pyrazolo [3,4-D] pyrimidin-4-amino (193 mg,0.5 mmol),<strong>[430-99-9]2-fluoroacrylic acid</strong> (52 mg, 0.58 mmol),HOBT (95 mg, 0.7 mmol)And 1-ethyl- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDCI) (134 mg, 0.7 mmol)Was dissolved in anhydrous DCM (10 ml)DIEA (271 mg, 2.1 mmol) was added,Stir at room temperature for 8 h. Diluted with ethyl acetate, washed with water, extracted with ethyl acetate twice,The combined organic phases were dried over anhydrous sodium sulfate and purified by column chromatography to give compound 12 (160 mg, yield 70percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With sulfuric acid; at 30 - 35℃; for 2h; | In a 100 ml three-necked flask, 14.8 g (0.2 mol) of butanol,And 8.64 g (0.096 mol) of <strong>[430-99-9]2-fluoroacrylic acid</strong>,Heated to 30 , 4.9g concentrated sulfuric acid (0.05mol), incubated 30-35 reaction 2h,Add saturated NaHCO3 to neutralize the system,20 g (0.23 mol) of methyl t-butyl ether was added for extraction,The organic phase obtained by distillation2-Fluoro-acrylate.Yield 90percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With 3-chloro-benzenecarboperoxoic acid; In dichloromethane; at 20℃; for 2h; | In a 250 ml four-necked flask, 2-fluoropropenal (8.89 g, 0.12 mol)m-cpba 26 g (0.15 mol),Dichloromethane 30g, incubated at 20 stirring 2h, cooled to about 0 ,Filtration, the filtrate was concentrated to dryness to give crude 2-fluoroacrylic acid,Crystallization with 10g n-heptane to obtain 2-fluoro acrylic acid products.Yield 92percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | With thionyl chloride; at 5 - 35℃; for 2h; | 8.64 g (0.096 mol) of <strong>[430-99-9]2-fluoroacrylic acid</strong> was mixed in a 100 ml three-necked flask at 5-10 ° C,And 13.1 g (0.11 mol) of thionyl chloride were added, the temperature was raised to 30 ° C, 6.4 g (0.2 mol) of methanol was added dropwise,Insulation 30-35 reaction 2h,The system was neutralized by adding aqueous NaHCO3 solution,20 g (0.23 mol) of methyl t-butyl ether was added for extraction,The organic phase was distilled to give methyl 2-fluoroacrylate. Yield 93percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
6.2 g | With dmap; diisopropyl-carbodiimide; In dichloromethane; at 20℃; for 8h;Inert atmosphere; Cooling with ice; | Under a nitrogen atmosphere,5.0 g of a compound represented by the formula (I-8-8) in a reaction vessel,4.8 g of the compound represented by the formula (I-8-9), 0.2 g of N, N-dimethylaminopyridine and 80 mL of dichloromethane were added.8.0 g of diisopropylcarbodiimide was added dropwise while cooling with ice, and the mixture was stirred at room temperature for 8 hours.The precipitate was removed by filtration and the filtrate was washed successively with 5percent hydrochloric acid and brine.Purification by column chromatography (silica gel, dichloromethane / hexane) gave 6.2 g of a compound represented by the formula (I-8-10). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
3.9 g | With dmap; diisopropyl-carbodiimide; In dichloromethane; | 7.0 g of a compound represented by the formula (I-5-8), 3.7 g of <strong>[430-99-9]2-fluoroacrylic acid</strong>, 0.1 g of N,N-dimethylaminopyridine, and 30 mL of dichloromethane were put into a reactor. 6.7 g of diisopropylcarbodiimide was dropwise added thereto and stirred. After ordinary post-treatment, this was purified through column chromatography and recrystallization to give 3.9 g of a compound represented by the formula (I-5-9). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; at 20℃; for 2h; | To a round bottom flask were added (R) -5- (*S) - (2-Methyl-4-phenoxyphenyl) -4-oxo-N- (piperidin-3-yl) -4, 5-dihydro-3H-1-thia-3, 5, 8-triazaacenaphthylene-2-carboxamide (Example 98, 31 mg, 0.062 mmol) , were added DMF (3 mL) , <strong>[430-99-9]2-fluoroacrylic acid</strong> (9 mg, 0.01 mmol) , triethylamine (21 mg, 0.188 mmol) , HATU (47 mg, 0.124 mmol) . The reaction mixture was stirred at rt for 2 h. Water was added and the precipitate was collected by filtration, then purified by silica gel chromatograph to give the title compound as a light yellow solid.[2060]MS (ESI) : mass calcd. for C30H26FN5O4S, 571.6 m/z found, 572.2 [M+H]+.1H NMR (400 MHz, CD3OD) : delta 8.34 (d, J 5.5 Hz, 1H) , 7.47 ?7.36 (m, 2H) , 7.33-7.25 (m, 1H) , 7.22-7.14 (m, 1H) , 7.13-7.03 (m, 3H) , 7.02-6.94 (m, 1H) , 6.08 (d, J 5.6 Hz, 1H) , 5.30-5.10 (m, 2H) , 4.63 ?3.77 (m, 3H) , 3.29 ?2.75 (m, 2H) , 2.15 (s, 3H) , 2.10 ?2.00 (m, 1H) , 1.95-1.84 (m, 1H) , 1.80 ?1.69 (m, 1H) , 1.67-1.55 (m, 1H) . |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; at -10 - 20℃; for 12h; | General procedure: Toa stirred solution of carboxylic acid (9 mmol) and DIPEA (18 mmol) in DMF (20mL) was added HATU (9 mmol) and compound 15(4.5 mmol) at -10 for15 min, then the reaction mixture was stirred at room temperature for 12h. Amixture of ethyl acetate and water was added, the organic layer was separatedand extracted with saturated brine, dried over Na2SO4 andconcentrated under reduced pressure. The residues were purified by silica gelcolumn chromatography eluting at a gradient of 0-20percent petroleum ether in ethylacetate, giving the target compound 9f-9i,9m-9o and 16 (Yield: 60percent-76percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
11.1 g | With toluene-4-sulfonic acid; In di-isopropyl ether; cyclohexane; for 12h;Dean-Stark; Reflux; | 10.0 g of the compound represented by the formula (I-8-4), 11.0 g of the compound represented by the formula (I-8-5), 0.8 g of p-toluenesulfonic acid monohydrate, 100 mL of cyclohexane and 100 mL of diisopropyl ether were put into a reactor equipped with a Dean-Stark apparatus. While removing water, this was heated under reflux for 12 hours. This was diluted with dichloromethane, and washed sequentially with an aqueous solution of 5percent sodium hydrogencarbonate and salt water. Purification through column chromatography (silica gel, dichloromethane) gave 11.1 g of the compound represented by the formula (I-6-8). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
35% | With pyridine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; at 50℃; for 2h; | N4-(4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)-3-methylphenyl)quinazoline-4,6-diam ine (100mg,0.26mmol), <strong>[430-99-9]2-fluoroacrylic acid</strong> (28mg, 0.39mmol) and 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride(150mg, 0.78mmol) was dissolved in pyridine (10mL) and the mixture was stirred at 50°C for 2 hours. The reactionsolution was evaporated to dryness under reduced pressure, then water was added, and the resulting mixture wasextracted three times with dichloromethane. The organic phases were combined, washed with saturated brine, driedand concentrated under reduced pressure to give a crude product, which was purified by column chromatography togive 40mg pale yellow solid with a yield of 35percent. LC-MS: 457.9 [M+H] detection value; 1H-NMR (400MHz, CDCl3) delta 9.22(s, 1H), 8.79 (s, 1H), 8.70 (s, 1H), 8.33 (s, 1H), 7.88 (d, 1H, J = 8.0 Hz), 7.81 - 7.76 (m, 2H), 7.58 (d, 1H, J = 8.0 Hz),7.15 (d, 1H, J = 8.0 Hz), 6.91 (s, 1H), 5.97 - 5.85 (m, 1H), 5.37 (d, 1H, J = 12.0 Hz), 2.27 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
35% | With pyridine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; at 100℃; for 18h; | General procedure: preparation of N-(4-((4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)-2-fluoroacrylamide: N4-(4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)-3-methylphenyl)quinazoline-4,6-diam ine (100mg,0.26mmol), <strong>[430-99-9]2-fluoroacrylic acid</strong> (28mg, 0.39mmol) and 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride(150mg, 0.78mmol) was dissolved in pyridine (10mL) and the mixture was stirred at 50°C for 2 hours. The reactionsolution was evaporated to dryness under reduced pressure, then water was added, and the resulting mixture wasextracted three times with dichloromethane. The organic phases were combined, washed with saturated brine, driedand concentrated under reduced pressure to give a crude product, which was purified by column chromatography togive 40mg pale yellow solid with a yield of 35percent. LC-MS: 457.9 [M+H] detection value; 1H-NMR (400MHz, CDCl3) delta 9.22(s, 1H), 8.79 (s, 1H), 8.70 (s, 1H), 8.33 (s, 1H), 7.88 (d, 1H, J = 8.0 Hz), 7.81 - 7.76 (m, 2H), 7.58 (d, 1H, J = 8.0 Hz),7.15 (d, 1H, J = 8.0 Hz), 6.91 (s, 1H), 5.97 - 5.85 (m, 1H), 5.37 (d, 1H, J = 12.0 Hz), 2.27 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With pyridine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; at 50℃; for 16h; | General procedure: preparation of N-(4-((4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)-2-fluoroacrylamide: N4-(4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)-3-methylphenyl)quinazoline-4,6-diam ine (100mg,0.26mmol), <strong>[430-99-9]2-fluoroacrylic acid</strong> (28mg, 0.39mmol) and 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride(150mg, 0.78mmol) was dissolved in pyridine (10mL) and the mixture was stirred at 50°C for 2 hours. The reactionsolution was evaporated to dryness under reduced pressure, then water was added, and the resulting mixture wasextracted three times with dichloromethane. The organic phases were combined, washed with saturated brine, driedand concentrated under reduced pressure to give a crude product, which was purified by column chromatography togive 40mg pale yellow solid with a yield of 35percent. LC-MS: 457.9 [M+H] detection value; 1H-NMR (400MHz, CDCl3) delta 9.22(s, 1H), 8.79 (s, 1H), 8.70 (s, 1H), 8.33 (s, 1H), 7.88 (d, 1H, J = 8.0 Hz), 7.81 - 7.76 (m, 2H), 7.58 (d, 1H, J = 8.0 Hz),7.15 (d, 1H, J = 8.0 Hz), 6.91 (s, 1H), 5.97 - 5.85 (m, 1H), 5.37 (d, 1H, J = 12.0 Hz), 2.27 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
61% | With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 8h; | 60 mg of 5-(7-methoxy-5-methylbenzothiophene-2-yl)-7-(azetidine-3-yl)-7H-pyrrole[2,3-d]pyrimidine -4-amine hydrochloride, 17 mg of 2-fluoro-propynoic acid and 80 mg of benzotriazol-1-tris(trimethylamino)-trifluorophosphate were dissolved in 2 ml of N,N-dimethylformamide, 0.12 ml of N,N-diisopropylethylamine was added dropwise, and the mixture was stirred at room temperature for 8 hours to quench the reaction. Water was added, and then the mixture was extracted with ethyl acetate. The organic phase was washed with a saturated aqueous solution of sodium chloride and dried over anhydrous sodium sulfate, filtered and concentrated, and the residue was isolated by column chromatography (dichloromethane: methanol = 97:3) to obtain 46 mg of light yellow solids, yield 61%. 1H NMR (300 MHz, DMSO-d6) delta 8.19 (s, 1H), 7.97 (s, 1H), 7.35 (s, 1H), 7.28 (s, 1H), 6.80 (s, 1H), 6.53 (s, 2H), 5.70-60 (m, 2H), 5.39-5.26 (m, 1H), 4.85 (s, 2H), 4.56-4.33 (m, 2H), 3.95 (s, 3H), 2.43 (s, 3H). |
Tags: 430-99-9 synthesis path| 430-99-9 SDS| 430-99-9 COA| 430-99-9 purity| 430-99-9 application| 430-99-9 NMR| 430-99-9 COA| 430-99-9 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :